Free radicals, metals and antioxidants in oxidative stress-induced cancer

Chemico-Biological Interactions

Volumn 160, Issue 1, 2006, Pages 1-40

  Valko, M ^a   Rhodes, C J ^b   Moncol, J ^a   Izakovic, M ^a   Mazur, M ^a  

^a SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

^b UNIVERSITY OF READING   (United Kingdom)

Author keywords

Antioxidants; Cancer; DNA damage; Metals; Oxidative stress; Protein damage; Reactive oxygen species; Signalling pathways

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CAROTENOID; CISPLATIN; COPPER ZINC SUPEROXIDE DISMUTASE; DOXORUBICIN; FLAVONOID; FREE RADICAL; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRON DEXTRAN; LYCOPENE; MANGANESE SUPEROXIDE DISMUTASE; MELATONIN; METAL; METHYSELENIC ACID; PINEAL BODY HORMONE; POLYPHENOL; QUERCETIN; RETINOIC ACID; SELENIUM; TETRATHIOMOLYBDIC ACID; THIOCTIC ACID; THIOL DERIVATIVE; THIOREDOXIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CARCINOGENESIS; CARCINOGENICITY; CELL AGING; CELL GROWTH; CLINICAL TRIAL; COLON CANCER; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTACT DERMATITIS; DNA DAMAGE; DOSE RESPONSE; DRUG FATALITY; DRUG MEGADOSE; DRUG SAFETY; DRUG STRUCTURE; FENTON REACTION; GENE MUTATION; GENETIC TRANSCRIPTION; HEMOLYTIC ANEMIA; HUMAN; KIDNEY INJURY; LIPID PEROXIDATION; LIVER FAILURE; LIVER INJURY; LUNG CANCER; MALE GENITAL SYSTEM DISEASE; METASTASIS; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHENOTYPE; PROSTATE CANCER; RADIATION INJURY; REGULATORY MECHANISM; SHORT SURVEY; SIGNAL TRANSDUCTION; STOMACH CANCER;

EID: 32444433202     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2005.12.009     Document Type: Review

References (286)

1. B. Halliwell, and J.M.C. Gutteridge Free Radicals in Biology and Medicine 3rd ed. 1999 Oxford University Press
2. E. Cadenas Biochemistry of oxygen toxicity Ann. Rev. Biochem. 58 1989 79 110
3. M. Valko, M. Izakovic, M. Mazur, C.J. Rhodes, and J. Telser Role of oxygen radicals in DNA damage and cancer incidence Mol. Cell. Biochem. 266 2004 37 56
4. G. Poli, G. Leonarduzzi, F. Biasi, and E. Chiarpotto Oxidative stress and cell signalling Curr. Med. Chem. 11 2004 1163 1182
5. B. Halliwell Antioxidants in human health and disease Ann. Rev. Nutr. 16 1996 33 50
6. M. Inoue, E.F. Sato, M. Nishikawa, A.M. Park, Y. Kira, I. Imada, and K. Utsumi Mitochondrial generation of reactive oxygen species and its role in aerobic life Curr. Med. Chem. 10 2003 2495 2505
7. 2 production in pigeon heart mitochondria FEBS Lett. 18 1971 261 263
8. E. Cadenas, and K.J.A. Davies Mitochondrial free radical generation, oxidative stress, and aging Free Rad. Biol. Med. 29 2000 222 230
9. C.Y. Li, and R.M. Jackson Reactive species mechanisms of cellular hypoxia-reoxygenation injury Am. J. Physiol.-Cell Physiol. 282 2002 C227 C241
10. E.M. Conner, and M.B. Grisham Inflammation, free radicals, and antioxidants Nutrition 12 1996 274 277
11. M. Gupta, K. Dobashi, E.L. Greene, J.K. Orak, and I. Singh Studies on hepatic injury and antioxidant enzyme activities in rat subcellular organelles following in vivo ischemia and reperfusion Mol. Cell. Biochem. 176 1997 337 347
12. J.E. Klaunig, and L.M. Kamendulis The role of oxidative stress in carcinogenesis Ann. Rev. Pharmacol. Toxicol. 44 2004 239 267
13. J.E. Klaunig, Y. Xu, S. Bachowski, and J. Jiang Free-radical oxygen-induced changes in chemical carcinogenesis K.B. Wallace Free Radical Toxicology 1997 Taylor & Francis London 375 400
14. I. Fridovich Biological effects of the superoxide radical Arch. Biochem. Biophys. 247 1986 1 11
15. A. Desideri, and M. Falconi Prokaryotic Cu, Zn superoxidies dismutases Biochem. Soc. Trans. 31 2003 1322 1325
16. C. Michiels, M. Raes, O. Toussaint, and J. Remacle Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell-survival against oxidative stress Free Rad. Biol. Med. 17 1994 235 248
17. M. Valko, H. Morris, and M.T.D. Cronin Metals, toxicity and oxidative stress Curr. Med. Chem. 12 2005 1161 1208
18. - in the production of OH - in-vitro and in-vivo Free Rad. Biol. Med. 16 1994 29 33
19. S.S. Leonard, G.K. Harris, and X.L. Shi Metal-induced oxidative stress and signal transduction Free Rad. Biol. Med. 37 2004 1921 1942
20. S.J. Stohs, and D. Bagchi Oxidative mechanisms in the toxicity of metal-ions Free Rad. Biol. Med. 18 1995 321 336
21. I. Pekarkova, S. Parara, V. Holecek, P. Stopka, L. Trefil, J. Racek, and R. Rokyta Does exogenous melatonin influence the free radicals metabolism and pain sensation in rat? Physiol. Res. 50 2001 595 602
22. S.I. Liochev, and I. Fridovich The Haber-Weiss cycle - 70 years later: an alternative view Redox report 7 2002 55 57
23. N. Pastor, H. Weinstein, E. Jamison, and M. Brenowitz A detailed interpretation of OH radical footprints in a TBP-DNA complex reveals the role of dynamics in the mechanism of sequence-specific binding J. Mol. Biol. 304 2000 55 68
24. J. Platenik, P. Stopka, M. Vejrazka, and S. Stipek Quinolinic acid-iron(II) complexes: slow autoxidation, but enhanced hydroxyl radical production in the Fenton reaction Free Rad. Res. 34 2001 445 459
25. T.D. Rae, P.J. Schmidt, R.A. Pufahl, V.C. Culotta, and T.V. O'Halloran Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase Science 284 1999 805 808
26. O. Kakhlon, and Z.I. Cabantchik The labile iron pool: characterization, measurement, and participation in cellular processes Free Rad. Biol. Med. 33 2002 1037 1046
27. A.M. Konijn, H. Glickstein, B. Vaisman, E.G. Meyron-Holtz, I.N. Slotki, and Z.I. Cabantchik The cellular labile iron pool and intracellular ferritin in K562 cells Blood 94 1999 2128 2134
28. P.C. Burcham Genotoxic lipid peroxidation products: their DNA damaging properties and role in formation of endogenous DNA adducts Mutagenesis 13 1998 287 305
29. N.A. Porter, S.E. Caldwell, and K.A. Mills Mechanisms of free-radical oxidation of unsaturated lipids Lipids 30 1995 277 290
30. J.M.C. Gutteridge Lipid-peroxidation and antioxidants as biomarkers of tissue-damage Clin. Chem. 41 1995 1819 1828
31. E. Cadenas, and H. Sies The lag phase Free Rad. Res. 28 1998 601 609
32. S. Archer Measurement of nitric-oxide in biological models FASEB J. 7 1993 349 360
33. W.K. Alderton, C.E. Cooper, and R.G. Knowles Nitric oxide synthases: structure, function and inhibition Biochem. J. 357 2001 593 615
34. L. Bergendi, L. Benes, Z. Durackova, and M. Ferencik Chemistry, physiology and pathology of free radicals Life Sci. 65 1999 1865 1874
35. U. Forstermann, J.P. Boissel, and H. Kleinert Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III) FASEB J. 12 1998 773 790
36. P. Ghafourifar, and E. Cadenas Mitochondrial nitric oxide synthase Trends Pharmacol. Sci. 26 2005 190 195
37. D.E. Koshland The molecule of the year Science 258 1992 1861
38. P. Klatt, and S. Lamas Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress Eur. J. Biochem. 267 2000 4928 4944
39. C.C. Chiueh Neuroprotective properties of nitric oxide Ann. NY Acad. Sci. 890 1999 301 311
40. A.C. Carr, M.R. McCall, and B. Frei Oxidation of LDL by myeloperoxidase and reactive nitrogen species - reaction pathways and antioxidant protection Arterioscl. Thromb. Vasc. Biol. 20 2000 1716 1723
41. M. Valko, D. Leibfritz, J. Moncol, M.T.D. Cronin, J. Telser, Mutual effect of free radicals, redox metals and antioxidants, FEBS J. (2006), submitted for publication.
42. F. Chen, M. Ding, V. Castranova, and X.L. Shi Carcinogenic metals and NF-kappa B activation Mol. Cell. Biochem. 222 2001 159 171
43. B. Halliwell, and J.M.C. Guteridge Role of free-radicals and catalytic metal-ions in human-disease - an overview Meth. Enzymol. 186 1990 1 85
44. D. Berg, M. Gerlach, M.B.H. Youdim, K.L. Double, L. Zecca, P. Riederer, and G. Becker Brain iron pathways and their relevance to Parkinson's disease J. Neurochem. 79 2001 225 236
45. C.W. Siah, D. Trinder, and J.K. Olynyk Iron overload Clin. Chim. Acta 358 2005 24 36
46. H. Ullen, K. Augustsson, C. Gustavsson, and G. Steineck Supplementary iron intake and risk of cancer: reversed causality? Cancer Lett. 114 1997 215 216
47. C.F. Babbs Free-radicals and the etiology of colon cancer Free Rad. Biol. Med. 8 1990 191 200
48. R.L. Nelson Dietary iron and colorectal-cancer risk Free Rad. Biol. Med. 12 1992 161 168
49. M. Valko, H. Morris, M. Mazur, P. Rapta, and R.F. Bilton Oxygen free radical generating mechanisms in the colon: do the semiquinones of Vitamin K play a role in the aetiology of colon cancer? Biochim. Biophys. Acta 1527 2001 161 166
50. K.V. Kowdley Iron, hemochromatosis, and hepatocellular carcinoma Gastroenterology 127 2004 S79 S86
51. Y. Deugnier, and B. Turlin Iron and hepatocellular carcinoma J. Gastroenterol. Hepatol. 16 2001 491 494
52. L.T. Stayner, D.A. Dankovic, and R.A. Lemen Occupational exposure to chrysotile asbestos and cancer risk: a review of the amphibole hypothesis Am. J. Public Health 86 1996 179 186
53. G. Bhasin, H. Kauser, and M. Athar Iron augments stage-I and stage-II tumor promotion in murine skin Cancer Lett. 183 2002 113 122
54. I. Gosriwatana, O. Loreal, S. Lu, P. Brissot, J. Porter, and R.C. Hider Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin Anal. Biochem. 273 1999 212 220
55. K.G. Daniel, R.H. Harbach, W.C. Guida, and Q.P. Dou Copper storage diseases: Menkes, Wilson's, and cancer Front. Biosci. 9 2004 2652 2662
56. M. Olivares, F. Pizarro, H. Speisky, B. Lonnerdal, and R. Uauy Copper in infant nutrition: safety of World Health Organization provisional guideline value for copper content of drinking water J. Pediatr. Gastroenterol. Nutr. 26 1998 251 257
57. R.J. Coates, N.S. Weiss, J.R. Daling, R.L. Rettmer, and G.R. Warnick Cancer risk in relation to serum copper levels Cancer Res. 49 1989 4353 4356
58. T.J. Wu, C.T. Sempos, J.L. Freudenheim, P. Muti, and E. Smith Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults Ann. Epidemiol. 14 2004 195 201
59. G.J. Brewer, R.D. Dick, D.K. Grover, V. LeClaire, M. Tseng, M. Wicha, K. Pienta, B.G. Redman, T. Jahan, V.K. Sondak, M. Strawderman, G. LeCarpentier, and S.D. Merajver Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study Clin. Cancer Res. 6 2000 1 10
60. A.D. Dayan, and A.J. Paine Mechanisms of chromium toxicity, carcinogenicity and allergenicity: review of the literature from 1985 to 2000 Human Exp. Toxicol. 20 2001 439 451
61. K.S. Kasprzak Possible role of oxidative damage in metal-induced carcinogenesis Cancer Invest. 13 1995 411 430
62. M. Cieslak-Golonka Toxic and mutagenic effects of chromium(VI). A review Polyhedron 15 1996 3667 3689
63. J. Singh, D.L. Carlisle, D.E. Pritchard, and S.R. Patierno Chromium-induced genotoxicity and apoptosis: relationship to chromium carcinogenesis (Review) Oncol. Rep. 5 1998 1307 1318
64. K.J. Liu, and X.L. Shi In vivo reduction of chromium(VI) and its related free radical generation Mol. Cell. Biochem. 222 2001 41 47
65. K.S. Kasprzak Oxidative DNA and protein damage in metal-induced toxicity and carcinogenesis Free Rad. Biol. Med. 32 2002 958 967 (and references therein)
66. A. Zhitkovich Importance of chromium-DNA adducts in mutagenicity and toxicity of chromium(VI) Chem. Res. Toxicol. 18 2005 3 11 (and references therein)
67. E. Kilic, R. Saraymen, A. Demiroglu, and E. Ok Chromium and manganese levels in the scalp hair of normals and patients with breast cancer Biol. Trace Elem. Res. 102 2004 19 25
68. P.M. Hanna, M.B. Kadiiska, and R.P. Mason Oxygen-derived free radical and active oxygen complex-formation from cobalt(II) chelates in vitro Chem. Res. Toxicol. 5 1992 109 115
69. S. Leonard, P.M. Gannett, Y. Rojanasakul, D. Schwegler-Berry, V. Castranova, V. Vallyathan, and X.L. Shi Cobalt-mediated generation of reactive oxygen species and its possible mechanism J. Inorg. Biochem. 70 1998 239 244
70. J.R. Bucher, J.R. Hailey, J.R. Roycroft, J.K. Haseman, R.C. Sills, S.L. Grumbein, P.W. Mellick, and B.J. Chou Inhalation toxicity and carcinogenicity studies of cobalt sulfate Toxicol. Sci. 49 1999 56 67
71. Z. Nackerdien, K.S. Kasprzak, G. Rao, B. Halliwell, and M. Dizdaroglu Nickel(II)-dependent and cobalt(II)-dependent damage by hydrogen-peroxide to the DNA bases in isolated human chromatin Cancer Res. 51 1991 5837 5842
72. A. Hartwig, and T. Schwerdtle Interactions by carcinogenic metal compounds with DNA repair processes: toxicological implications Toxicol. Lett. 127 2002 47 54
73. J.R. Roth, J.G. Lawrence, and T.A. Bobik Cobalamin (coenzyme B-12): synthesis and biological significance Ann. Rev. Microbiol. 50 1996 137 181
74. D.C. Crans, J.J. Smee, E. Gaidamauskas, and L.Q. Yang The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds Chem. Rev. 104 2004 849 902
75. 2- Arch. Biochem. Biophys. 279 1990 1 7
76. A.M. Evangelou Vanadium in cancer treatment Crit. Rev. Oncol. Hematol. 42 2002 249 265
77. M. Ding, P.M. Gannett, Y. Rojanasakul, K.J. Liu, and X.L. Shi One-electron reduction of vanadate by ascorbate and related free-radical generation at physiological pH J. Inorg. Biochem. 55 1994 101 112
78. Z. Zhang, C.S. Huang, J.X. Li, S.S. Leonard, R. Lanciotti, L. Butterworth, and X.L. Shi Vanadate-induced cell growth regulation and the role of reactive oxygen species Arch. Biochem. Biophys. 392 2001 311 320
79. L.V. Favreau, and C.B. Pickett The rat quinone reductase antioxidant response element - identification of the nucleotide-sequence required for basal and inducible activity and detection of antioxidant response element-binding proteins in hepatoma and non-hepatoma cell-lines J. Biol. Chem. 270 1995 24468 24474
80. A. Galan, L. Garcia-Bermejo, A. Troyano, N.E. Vilaboa, C. Fernandez, E. de Blas, and P. Aller The role of intracellular oxidation in death induction (apoptosis and necrosis) in human promonocytic cells treated with stress inducers (cadmium, heat, X-rays) Eur. J. Cell. Biol. 80 2001 312 320
81. M. Watanabe, K. Henmi, K. Ogawa, and T. Suzuki Cadmium-dependent generation of reactive oxygen species and mitochondrial DNA breaks in photosynthetic and non-photosynthetic strains of Euglena gracilis Comp. Biochem. Physiol. C-Toxicol. Pharmacol. 134 2003 227 234
82. D.J. Price, and J.G. Joshi Ferritin. Binding of beryllium and other divalent metal ions J. Biol. Chem. 258 1983 10873 10880
83. E. Casalino, C. Sblano, and C. Landriscina Enzyme activity alteration by cadmium administration to rats: the possibility of iron involvement in lipid peroxidation Arch. Biochem. Biophys. 346 1997 171 179
84. W. Watjen, and D. Beyersmann Cadmium-induced apoptosis in C6 glioma cells: influence of oxidative stress Biometals 17 2004 65 78
85. M. Waisberg, P. Joseph, B. Hale, and D. Beyersmann Molecular and cellular mechanisms of cadmium carcinogenesis Toxicology 192 2003 95 117
86. K. Yamanaka, F. Takabayashi, M. Mizoi, Y. An, A. Hasegawa, and S. Okada Oral exposure of dimethylarsinic acid, a main metabolite of inorganic arsenics, in mice leads to an increase in 8-oxo-2′-deoxyguanosine level, specifically in the target organs for arsenic carcinogenesis Biochem. Biophys. Res. Commun. 287 2001 66 70
87. C.D. Kamat, D.E. Green, S. Curilla, L. Warnke, J.W. Hamilton, S. Sturup, C. Clark, and M.A. Ihnat Role of HIF signaling on tumorigenesis in response to chronic low-dose arsenic administration Toxicol. Sci. 86 2005 248 257
88. E. Garcia-Chavez, A. Santamaria, F. Diaz-Barriga, P. Mandeville, B.I. Juarez, and M.E. Jimenez-Capdeville Arsenite-induced formation of hydroxyl radical in the striatum of awake rats Brain Res. 976 2003 82 89
89. P. Roy, and A. Saha Metabolism and toxicity of arsenic: a human carcinogen Curr. Sci. 82 2002 38 45
90. M.P. Waalkes, J. Liu, J.M. Ward, and L.A. Diwan Mechanisms underlying arsenic carcinogenesis: hypersensitivity of mice exposed to inorganic arsenic during gestation Toxicology 198 2004 31 38
91. Y.W. Lee, C.B. Klein, B. Kargacin, K. Salnikow, J. Kitahara, K. Dowjat, A. Zhitkovich, N.T. Christie, and M. Costa Carcinogenic nickel silences gene-expression by chromatin condensation and DNA methylation - a new model for epigenetic carcinogens Mol. Cell. Biol. 15 1995 2547 2557
92. D.G. Barceloux Nickel J. Toxicol. Clin. Toxicol. 37 1999 239 258
93. T.K. Grimsrud, S.R. Berge, T. Haldorsen, and A. Andersen Can lung cancer risk among nickel refinery workers be explained by occupational exposures other than nickel? Epidemiology 16 2005 146 154
94. V.J. Feron, J.H.E. Arts, C.F. Kuper, P.J. Slootweg, and R.A. Woutersen Health risks associated with inhaled nasal toxicants Crit. Rev. Toxicol. 31 2001 313 347
95. K.B. Beckman, and B.N. Ames Oxidative decay of DNA J. Biol. Chem. 272 1997 19633 19636
96. M. Dizdaroglu, P. Jaruga, M. Birincioglu, and H. Rodriguez Free radical-induced damage to DNA: mechanisms and measurement Free Rad. Biol. Med. 32 2002 1102 1115
97. L.J. Marnett Oxyradicals and DNA damage Carcinogenesis 21 2000 361 370
98. M.S. Cooke, M.D. Evans, M. Dizdaroglu, and J. Lunec Oxidative DNA damage: mechanisms, mutation, and disease FASEB J. 17 2003 1195 1214
99. M.K. Shigenaga, C.J. Gimeno, and B.N. Ames Urinary 8-hydroxy-2′- deoxyguanosine as a biological marker of in vivo oxidative DNA damage Proc. Natl. Acad. Sci. U.S.A. 86 1989 9697 9701
100. H. Kasai, N. Iwamoto-Tanaka, T. Miyamoto, K. Kawanami, S. Kawanami, R. Kido, and M. Ikeda Life style and urinary 8-hydroxydleoxyguanosine, a marker of oxidative DNA damage: Effects of exercise, working conditions, meat intake, body mass index, and smoking Jpn. J. Cancer Res. 92 2001 9 15
101. A.R. Collins, J. Brown, M. Bogdanov, J. Cadet, M. Cooke, and T. Douki Comparison of different methods of measuring 8-oxoguanine as a marker of oxidative DNA damage Free Rad. Res. 32 2000 333 341
102. G.C. Brown, and V. Borutaite Nitric oxide, mitochondria, and cell death IUBMB Life 52 2001 189 195
103. J.S. Penta, F.M. Johnson, J.T. Wachsman, and W.C. Copeland Mitochondrial DNA in human malignancy Mutat. Res.-Rev. Mutat. Res. 488 2001 119 133
104. M.D. Evans, M. Dizdaroglu, and M.S. Cooke Oxidative DNA damage and disease: induction, repair and significance Mutat. Res.-Rev. Mutat. Res. 567 2004 1 61
105. H. Kasai Chemistry-based studies on oxidative DNA damage: formation, repair, and mutagenesis Free Rad. Biol. Med. 33 2002 450 456
106. H. Kasai, P.F. Crain, Y. Kuchino, S. Nishimura, A. Ootsuyama, and H. Tanooka Formation of 8-hydroxyguanine moiety in cellular DNA by agents producing oxygen radicals and evidence for its repair Carcinogenesis 7 1986 1849 1851
107. M.H. Chung, H. Kasai, D.S. Jones, H. Inoue, H. Ishikawa, E. Ohtsuka, and S. Nishimura An endonuclease activity of Escherichia coli that specifically removes 8-hydroxyguanine residues from DNA Mutat. Res. 254 1991 1 12
108. C. Giulivi, A. Boveris, and E. Cadenas Hydroxyl radical generation during mitochondrial electron-transfer and the formation of 8-hydroxydesoxyguanosine in mitochondrial DNA Arch. Biochem. Biophys. 316 1995 909 916
109. H. Esterbauer, R.J. Schaur, and H. Zollner Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes Free Rad. Biol. Med. 11 1991 81 128
110. L.J. Marnett Lipid peroxidation - DNA damage by malondialdehyde Mut. Res.-Fund. Mol. Mech. Mutagen. 424 1999 83 95
111. J.R. Bucher, M. Tien, and S.D. Aust The requirement for ferric in the initiation of lipid peroxidation by chelated ferrous iron Biochem. Biophys. Res. Commun. 111 1983 777 784
112. B.R. Bacon, A.S. Tavill, G.M. Brittenham, C.H. Park, and R.O. Recknagel Hepatic lipid peroxidation in vivo in rats with chronic iron overload J. Clin. Invest. 71 1983 429 439
113. I. Pinchuk, E. Schnitzer, and D. Lichtenberg Kinetic analysis of copper-induced peroxidation of LDL Biochim. Biophys. Acta-Lipids Lipid Metab. 1389 1998 155 172
114. A. Nyska, and R. Kohen Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification Toxicol. Pathol. 30 2002 620 650
115. M.Y. Wang, K. Dhingra, W.N. Hittelman, J.G. Liehr, M. deAndrade, and D.H. Li Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues Cancer Epidemiol. Biomark. Prev. 5 1996 705 710
116. S.P. Fink, G.R. Reddy, and L.J. Marnett Mutagenicity in Escherichia coli of the major DNA adduct derived from the endogenous mutagen malondialdehyde Proc. Natl. Acad. Sci. U.S.A. 94 1997 8652 8657
117. H. Mao, N.C. Schnetz-Boutaud, J.P. Weisenseel, L.J. Marnett, and M.P. Stone Duplex DNA catalyzes the chemical rearrangement of a malondialdehyde deoxyguanosine adduct Proc. Natl. Acad. Sci. U.S.A. 96 1999 6615 6620
118. N. Fedtke, J.A. Boucheron, V.E. Walker, and J.A. Swenberg Vinyl chloride-induced DNA adducts. Part 2. Formation and persistence of 7-(2′-oxoethyl)guanine and n2,3-ethenoguanine in rat-tissue DNA Carcinogenesis 11 1990 1287 1292
119. K.C. Cheng, B.D. Preston, D.S. Cahill, M.K. Dosanjh, B. Singer, and L.A. Loeb The vinyl-chloride DNA derivative n2,3-ethenoguanine produces G-A transitions in Escherichia coli Proc. Natl. Acad. Sci. U.S.A. 88 1991 9974 9978
120. M. Saparbaev, K. Kleibl, and J. Laval Escherichia coli, Saccharomyces cerevisiae, rat and human 3-methyladenine DNA glycosylases repair 1, n-6-ethenoadenine when present in DNA Nucl. Acids Res. 23 1995 3750 3755
121. R.G. Nath, and F.L. Chung Detection of exocyclic 1,N-2- propanodeoxyguanosine adducts as common DNA lesions in rodents and humans Proc. Natl. Acad. Sci. U.S.A. 91 1994 7491 7495
122. S. Khullar, C.V. Varaprasad, and F. Johnson Postsynthetic generation of a major acrolein adduct of 2′-deoxyguanosine in oligomeric DNA J. Med. Chem. 42 1999 947 950
123. E.R. Stadtman Role of oxidant species in aging Curr. Med. Chem. 11 2004 1105 1112
124. E.R. Stadtman Protein oxidation and aging Science 257 1992 1220 1224
125. E.R. Stadtman Metal ion-catalyzed oxidation of proteins - biochemical-mechanism and biological consequences Free Rad. Biol. Med. 9 1990 315 325
126. K.J.A. Davies Protein damage and degradation by oxygen radicals. Part 1. General-aspects J. Biol. Chem. 262 1987 9895 9901
127. K.J.A. Davies, M.E. Delsignore, and S.W. Lin Protein damage and degradation by oxygen radicals. Part 2. Modification of amino-acids J. Biol. Chem. 262 1987 9902 9907
128. K.J.A. Davies, and M.E. Delsignore Protein damage and degradation by oxygen radicals. Part 3. Modification of secondary and tertiary structure J. Biol. Chem. 262 1987 9908 9913
129. K.J.A. Davies, S.W. Lin, and R.E. Pacifici Protein damage and degradation by oxygen radicals. Part 4. Degradation of denatured protein J. Biol. Chem. 262 1987 9914 9920
130. K.D. Welch, M.E. van Eden, and S.D. Aust Modification of ferritin during iron loading Free Rad. Biol. Med. 31 2001 999 1006
131. C. Giulivi, and E. Cadenas Heme protein radicals: formation, fate, and biological consequences Free Rad. Biol. Med. 24 1998 269 279
132. R.L. Levine, L. Mosoni, B.S. Berlett, and E.R. Stadtman Methionine residues as endogenous antioxidants in proteins Proc. Natl. Acad. Sci. U.S.A. 93 1996 15036 15040
133. E.R. Stadtman Protein oxidation in aging and age-related diseases Ann. New York Acad. Sci. 928 2001 22 38
134. R.L. Levine, and E.R. Stadtman Oxidative modification of proteins during aging Exp. Gerontol. 36 2001 1495 1502
135. V.J. Thannickal, and B.L. Fanburg Reactive oxygen species in cell signaling Am. J. Physiol. Lung Cell. Mol. Physiol. 279 2000 L1005 L1028
136. K. Hensley, K.A. Robinson, S.P. Gabbita, S. Salsman, and R.A. Floyd Reactive oxygen species, cell signaling, and cell injury Free Rad. Biol. Med. 28 2000 1456 1462
137. V.P. Sah, T.M. Seasholtz, S.A. Sagi, and J.H. Brown The role of Rho in G protein-coupled receptor signal transduction Ann. Rev. Pharmacol. Toxicol. 40 2000 459 489
138. H.J. Palmer, and K.E. Paulson Reactive oxygen species and antioxidants in signal transduction and gene expression Nutr. Rev. 55 1997 353 361
139. C.J. Lowenstein, J.L. Dinerman, and S.H. Snyder Nitric-oxide - a physiological messenger Ann. Intern. Med. 120 1994 227 237
140. P. Storz Reactive oxygen species in tumor progression Front. Biosci. 10 2005 1881 1896
141. G. Neufeld, T. Cohen, S. Gengrinovitch, and Z. Poltorak Vascular endothelial growth factor (VEGF) and its receptors FASEB J. 13 1999 9 22
142. C.A. Hazzalin, and L.C. Mahadevan MAPK-regulated transcription: a continuously variable gene switch? Nat. Rev. Mol. Cell. Biol. 3 2002 30 40
143. J.M. English, and M.H. Cobb Pharmacological inhibitors of MAPK pathways Trends Pharmacol. Sci. 23 2002 40 45
144. B.A. Ballif, and J. Blenis Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals Cell. Growth Differ. 12 2001 397 408
145. M. Mulder Role of Ras and Mapks in TGF beta signaling Cytokine Growth Factor Rev. 11 2000 23 35
146. T. Obata, G.E. Brown, and M.B. Yaffe MAP kinase pathways activated by stress: the p38 MAPK pathway Crit. Care Med. 28 2000 N67 N77
147. R. Seger, and E.G. Krebs Protein kinases. Part 7. The MAPK signaling cascade FASEB J. 9 1995 726 735
148. E. Cano, and L.C. Mahadevan Parallel signal-processing among mammalian MAPKs Trends Biochem. Sci. 20 1995 117 122
149. R.J. Davis Mapks - new JNK expands the group Trends Biochem. Sci. 19 1994 470 473
150. Y.S. Bae, S.W. Kang, M.S. Seo, I.C. Baines, E. Tekle, and P.B. Chock Epidermal growth factor (EGF)-induced generation of hydrogen peroxide - role in EGF receptor-mediated tyrosine phosphorylation J. Biol. Chem. 272 1997 217 221
151. 2 in the platelet-derived growth factor-induced transcription of the gamma-glutamylcysteine synthetase heavy subunit Cell. Mol. Life Sci. 59 2002 1388 1394
152. M. Sundaresan, Z.X. Yu, V.J. Ferrans, D.J. Sulciner, J.S. Gutkind, K. Irani, P.J. Glodschmidt-Clermont, and T. Finkel Regulation of reactive-oxygen-species generation in fibroblasts by Rac1 Biochem. J. 318 1996 379 382
153. I.L.C. Chapple Reactive oxygen species and antioxidants in inflammatory diseases J. Clin. Periodontol. 24 1997 287 296
154. J. Drevs, M. Medinger, C. Schmidt-Gersbach, R. Weber, and C. Unger Receptor tyrosine kinases: the main targets for new anticancer therapy Curr. Drug Target. 4 2003 113 121
155. P.P. Simeonova, and M.I. Luster Arsenic carcinogenicity: relevance of c-Src activation Mol. Cell. Biochem. 234 2002 277 282
156. E.S. Kim, F.R. Khuri, and R.S. Herbst Epidermal growth factor receptor biology (IMC-C225) Curr. Opinion Oncol. 13 2001 506 513
157. S.S. Leonard, J.J. Bower, and X. Shi Metal-induced toxicity, carcinogenesis, mechanisms and cellular responses Mol. Cell. Biochem. 255 2004 3 10
158. J. Abe, and B.C. Berk Fyn and JAK2 mediate Ras activation by reactive oxygen species J. Biol. Chem. 274 1999 21003 21010
159. F. Esposito, G. Chirico, N.M. Gesualdi, I. Posadas, R. Ammendola, T. Russo, G. Cirino, and F. Cimino Protein kinase B activation by reactive oxygen species is independent of tyrosine kinase receptor phosphorylation and requires Src activity J. Biol. Chem. 278 2003 20828 20834
160. J. Vachtenheim Occurrence of ras mutations in human lung cancer Neoplasma 44 1997 145 149 (Minireview)
161. M. Wei, H. Wanibuchi, K. Morimura, S. Iwai, K. Yoshida, G. Endo, D. Nakae, and S. Fikushima Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors Carcinogenesis 23 2002 1387 1397
162. A. Salmeen, and D. Barford Functions and mechanisms of redox regulation of cysteine-based phosphatases Antioxidants Redox Signal. 7 2005 560 577
163. W.C. Barrett, J.P. DeGnore, S. Konig, H.M. Fales, Y.F. Keng, Z.Y. Zhang, M.B. Yim, and P.B. Chock Regulation of PTP1B via glutathionylation of the active site cysteine 215 Biochemistry 38 1999 6699 6705
164. 2 or heat shock is mediated by phosphoinositide 3-kinase and not by mitogen-activated protein kinase-activated protein kinase-2 Biochem. J. 336 1998 241 246
165. C.S. Huang, J.X. Li, M. Ding, S.S. Leonard, L.Y. Wang, V. Castranova, V. Vallyathan, and X.L. Shi UV induces phosphorylation of protein kinase B (Akt) at Ser-473 and Thr-308 in mouse epidermal Cl 41 cells through hydrogen peroxide J. Biol. Chem. 276 2001 40234 40240
166. A.B. Parekh, and R. Penner Store depletion and calcium influx Physiol. Rev. 77 1997 901 930
167. R. Gopalakrishna, and S. Jaken Protein kinase C signaling and oxidative stress Free Rad. Biol. Med. 28 2000 1349 1361
168. E.C. Dempsey, A.C. Newton, D. Mochly-Rosen, A.P. Fields, M.E. Reyland, P.A. Insel, and R.P. Messing Protein kinase C isozymes and the regulation of diverse cell responses Am. J. Physiol.-Lung Cell Mol. Physiol. 279 2000 L429 L438
169. M. Lopez-Ilasaca, P. Crespo, P.G. Pellici, J.S. Gutkind, and R. Wetzker Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase gamma Science 275 1997 394 397
170. J.M. Kyriakis, and J. Avruch Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation Physiol. Rev. 81 2001 807 869
171. K.E. Iles, and H.J. Forman Macrophage signaling and respiratory burst Imunol. Res. 26 2002 95 105
172. M. Torres, and H.J. Forman Activation of several MAP kinases upon stimulation of rat alveolar macrophages: role of the NADPH oxidase Arch. Biochem. Biophys. 366 1999 231 239
173. Y. Sun, and L.W. Oberley Redox regulation of transcriptional activators Free Rad. Biol. Med. 21 1996 335 348
174. A. Rao, C. Luo, and P.G. Hogan Transcription factors of the NFAT family: regulation and function Ann. Rev. Immunol. 15 1997 707 747
175. A.J. Whitmarsh, and R.J. Davis Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways J. Mol. Med.-JMM 74 1996 589 607
176. R. Pinkus, L.M. Weiner, and V. Daniel Role of oxidants and antioxidants in the induction of AP-1, NF-kappa B, and glutathione S-transferase gene expression J. Biol. Chem. 271 1996 13422 13429
177. T.C. Hsu, M.R. Young, J. Cmarik, and N.H. Colburn Activator protein 1 (AP-1)- and nuclear factor kappa B (NF-kappa B)-dependent transcriptional events in carcinogenesis Free Rad. Biol. Med. 28 2000 1338 1348
178. 2+]I in induction of c-Fos, c-Jun, and c-Myc messenger-RNA in rat Pte after oxidative stress FASEB J. 6 1992 919 924
179. V. Pande, and M.J. Ramos NF-kappa B in human disease: current inhibitors and prospects for de novo structure based design of inhibitors Curr. Med. Chem. 12 2005 357 374
180. K.I. Amiri, and A. Richmond Role of nuclear factor-kappa B in melanoma Cancer Metast. Rev. 24 2005 301 313
181. J.A. Knight Free radicals, antioxidants, and the immune system Ann. Clin. Lab. Sci. 30 2000 145 158
182. J.S. Orange, O. Levy, and R.S. Geha Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappa B activation Immunol. Rev. 203 2005 21 37
183. G. Hughes, M.P. Murphy, and E.C. Ledgerwood Mitochondrial reactive oxygen species regulate the temporal activation of nuclear factor kappa B to modulate tumour necrosis factor-induced apoptosis: evidence from mitochondria-targeted antioxidants Biochem. J. 389 2005 83 89
184. V. Baud, and M. Karin Signal transduction by tumor necrosis factor and its relatives Trends Cell Biol. 11 2001 372 377
185. L.J. Hofseth, S.P. Hussain, and C.C. Harris p53: 25 years after its discovery Trends. Pharm. Sci. 25 2004 177 181
186. M. Hollstein, D. Sidransky, B. Vogelstein, and C.C. Harris p53 Mutations in human cancer Science 253 1991 49 53
187. J. Renzing, S. Hansen, and D.P. Lane Oxidative stress is involved in the UV activation of p53 J. Cell. Sci. 109 1996 1105 1112
188. K. Polyak, Y. Xia, J.L. Zweier, K.W. Kinzler, and B. Vogelstein A model for p53-induced apoptosis Nature 389 1997 300 305
189. M.K. Kim, Y.G. Park, G. Gong, and S.H. Ahn Breast cancer, serum antioxidant vitamins, and p53 protein overexpression Nutr. Cancer-Int. J. 43 2002 159 166
190. S. Ranganathan, J. Joseph, and J.L. Mehta Aspirin inhibits human coronary artery endothelial cell proliferation by upregulation of p53 Biochem. Biophys. Res. Commun. 301 2003 143 146
191. S.W. Wang, and X.L. Shi Mechanisms of Cr(VI)-induced p53 activation: the role of phosphorylation, mdm2 and ERK Carcinogenesis 22 2001 757 762
192. L. Maehle, R.A. Metcalf, D. Ryberg, W.P. Bennett, C.C. Harris, and A. Haugen Altered p53 gene structure and expression in human epithelial-cells after exposure to nickel Cancer Res. 52 1992 218 221
193. C.S. Huang, W.Y. Ma, J.X. Li, and Z.G. Dong Arsenic induces apoptosis through a c-Jun NH2-terminal kinase-dependent, p53-independent pathway Cancer Res. 59 1999 3053 3058
194. A.M. Salazar, E. Calderon-Aranda, M.E. Cebrian, M. Sordo, A. Bendesky, A. Gomez-Munoz, L. Acosta-Saavedra, and P. Ostrosky-Wegman p53 expression in circulating lymphocytes of non-melanoma skin cancer patients from an arsenic contaminated region in Mexico. A pilot study Mol. Cell. Biochem. 255 2004 25 31
195. A.C. Souici, J. Mirkovitch, P. Hausel, L.K. Keefer, and E. Felley-Bosco Transition mutation in codon 248 of the p53 tumor suppressor gene induced by reactive oxygen species and a nitric oxide-releasing compound Carcinogenesis 21 2000 281 287
196. S. Jauliac, C. Lopez-Rodriguez, L.M. Shaw, L.F. Brown, A. Rao, and A. Toker The role of FAT transcription factors in integrin-mediated carcinoma invasion Nat. Cell Biol. 4 2002 540 544
197. C.W. Chow, M. Rincon, J. Cavanagh, M. Dickens, and R.J. Davis Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway Science 278 1997 1638 1641
198. G.L. Semenza HIF-1: mediator of physiological and pathophysiological responses to hypoxia J. Appl. Physiol. 88 2000 1474 1480
199. H. Zhong, A.M. De Marzo, E. Laughner, M. Lim, D.A. Hilton, D. Zagzag, P. Buechler, W.B. Isaacs, G.L. Semenza, and J.W. Simons Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases Cancer Res. 59 1999 5830 5835
200. N. Gao, B.H. Jiang, S.S. Leonard, L. Corum, Z. Zhang, J.R. Roberts, J. Antonini, J.Z. Zheng, D.C. Flynn, V. Castranova, and X.L. Shi p38 Signaling-mediated hypoxia-inducible factor 1 alpha and vascular endothelial growth factor induction by Cr(VI) in DU145 human prostate carcinoma cells J. Biol. Chem. 277 2002 45041 45048
201. J.T. Hwang, M. Lee, S.N. Jung, H.J. Lee, I. Kang, S.S. Kim, and J. Ha AMP-activated protein kinase activity is required for vanadate-induced hypoxia-inducible factor 1 alpha expression in DU145 cells Carcinogenesis 25 2004 2497 2507
202. G.P. Trueba, G.M. Sanchez, and A. Giuliani Oxygen free radical and antioxidant defense mechanism in cancer Front. Biosci. 9 2004 2029 2044
203. J.E. Trosko, and R.J. Ruch Gap junctions as targets for cancer chemoprevention and chemotherapy Curr. Drug Target. 3 2002 465 482
204. K.Z. Guyton, and T.W. Kensler Oxidative mechanisms in carcinogenesis Br. Med. Bull. 49 1993 523 544
205. B.N. Ames, and L.S. Gold Too many rodent carcinogens - mitogenesis increases mutagenesis Science 249 1990 970 971
206. M.A. Trush, and T.W. Kensler An overview of the relationship between oxidative stress and chemical carcinogenesis Free Rad. Biol. Med. 10 1991 201 209
207. M.O. Hengartner The biochemistry of apoptosis Nature 407 2000 770 776
208. M. Oren Decision making by p53: life, death and cancer Cell Death Differ. 10 2003 431 442
209. S.P. Hussain, L.J. Hofseth, and C.C. Harris Radical causes of cancer Nat. Rev. Cancer 3 2003 276 285
210. J.E. Trosko The role of stem cells and gap junctional intercellular communication in carcinogenesis J. Biochem. Mol. Biol. 36 2003 43 48
211. J.E. Trosko, C.C. Chang, B.V. Madhukar, and E. Dupont Oncogenes, tumor suppressor genes and intercellular communication in the oncogeny as partially blocked ontogeny hypothesis O.H. Iversen New Frontiers in Cancer Causation 1993 Taylor & Francis Washington, DC 181 197
212. S. Loft, and H.E. Poulsen Cancer risk and oxidative DNA damage in man J. Mol. Med.-JMM 74 1996 297 312
213. D. Dreher, and A.F. Junod Role of oxygen free radicals in cancer development Eur. J. Cancer 32A 1996 30 38
214. P. Carmeliet Mechanisms of angiogenesis and arteriogenesis Nat. Med. 6 2000 389 395
215. J.M. Mates, C. Perez-Gomez, and I.N. De Castro Antioxidant enzymes and human diseases Clin. Biochem. 32 1999 595 603
216. M.R. McCall, and B. Frei Can antioxidant vitamins materially reduce oxidative damage in humans? Free Rad. Biol. Med. 26 1999 1034 1053
217. H. Sies, W. Stahl, and A. Sevanian Nutritional, dietary and postprandial oxidative stress J. Nutr. 135 2005 969 972
218. J.M. Mc Cord, and I. Fridovich Superoxide dismutase an enzymic function for erythrocuprein (hemocuprein) J. Biol. Chem. 244 1969 60409 60455
219. G.N. Landis, and J. Tower Superoxide dismutase evolution and life span regulation Mech. Ageing Dev. 126 2005 365 379
220. L. Behrend, G. Henderson, and R.M. Zwacka Reactive oxygen species in oncogenic transformation Biochem. Soc. Trans. 31 2003 1441 1444
221. L.W. Oberley Role of antioxidant enzymes in cell immortalization and transformation Mol. Cell. Biochem. 84 1998 147 153
222. Y.F. Jiang Complex roles of tissue inhibitors of metalloproteinases in cancer Oncogene 21 2002 2245 2252
223. D.P. Barondeau, C.J. Kassmann, C.K. Bruns, J.A. Tainer, and E.D. Getzoff Nickel superoxide dismutase structure and mechanism Biochemistry 43 2004 8038 8047
224. S. Kojo Vitamin C: basic metabolism and its function as an index of oxidative stress Curr. Med. Chem. 11 2004 1041 1064
225. A. Carr, and B. Frei Does Vitamin C act as a pro-oxidant under physiological conditions? FASEB J. 13 1999 1007 1024
226. S. Kasparova, V. Brezova, M. Valko, J. Horecky, V. Mlynarik, T. Liptaj, O. Vancova, O. Ulicna, and D. Dobrota Study of the oxidative stress in a rat model of chronic brain hypoperfusion Neurochem. Int. 46 2005 601 611
227. S. Cuzzorcrea, C. Thiemermann, and D. Salvemini Potential therapeutic effect of antioxidant therapy in shock and inflammation Curr. Med. Chem. 11 2004 1147 1162
228. K.L. Retsky, K. Chen, J. Zeind, and B. Frei Inhibition of copper-induced LDL oxidation by Vitamin C is associated with decreased copper-binding to LDL and 2-oxo-histidine formation Free Rad. Biol. Med. 26 1999 90 98
229. E. Cameron, and L. Pauling Supplemental ascorbate in supportive treatment of cancer - prolongation of survival times in terminal human cancer. Part 1 Proc. Natl. Acad. Sci. U.S.A. 73 1976 3685 3689
230. W.C. You, L. Zhang, M.H. Gail, Y.S. Chang, W.D. Liu, J.L. Ma, J.Y. Li, M.L. Jin, Y.R. Hu, C.S. Yang, M.J. Blaser, P. Correa, W.J. Blot, J.F. Fraumeni, and G.W. Xu Gastric cancer: Helicobacter pylori, serum Vitamin C, and other risk factors J. Natl. Cancer Inst. 92 2000 1607 1612
231. P. Knekt, R. Jarvinen, R. Seppanen, A. Rissanen, A. Aromaa, O.P. Heinonen, D. Albanes, M. Heinonen, E. Pukkala, and L. Teppo Dietary antioxidants and the risk of lung-cancer Am. J. Epidemiol. 134 1991 471 479
232. S.A. Kang, Y.J. Jang, and H. Park In vivo dual effects of Vitamin C on paraquat-induced lung damage: dependence on released metals from the damaged tissue Free Rad. Res. 28 1998 93 107
233. S.H. Lee, T. Oe, and I.A. Blair Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins Science 292 2001 2083 2086
234. J. Suh, B.Z. Zhu, and B. Frei Ascorbate does not act as a pro-oxidant towards lipids and proteins in human plasma exposed to redox-active transition metal ions and hydrogen peroxide Free Rad. Biol. Med. 34 2003 1306 1314
235. M.A. Smith, P.L.R. Harris, L.M. Sayre, J.S. Beckman, and G. Perry Widespread peroxynitrite-mediated damage in Alzheimer's disease J. Neurosci. 17 1997 2653 2657
236. I.D. Podmore, H.R. Griffiths, K.E. Herbert, N. Mistry, P. Mistry, and J. Lunec Vitamin C exhibits pro-oxidant properties Nature 392 1998 559
237. G.W. Burton, and K.U. Ingold Vitamin E as an in vitro and in vivo antioxidant Ann. NY Acad. Sci. 570 1989 7 22
238. W.A. Pryor Vitamin E and heart disease: basic science to clinical intervention trials Free Rad. Biol. Med. 28 2000 141 164
239. E. White, J.S. Shannon, and R.E. Patterson Relationship between vitamin and calcium supplement use and colon cancer Cancer Epidemiol. Biomark. Prev. 6 1997 769 774
240. E.R. Greenberg, J.A. Baron, T.D. Tosteson, D.H. Freeman, G.J. Beck, and J.H. Bond Clinical-trial of antioxidant vitamins to prevent colorectal adenoma N. Engl. J. Med. 331 1994 141 147
241. E.R. Miller, R. Pastor-Barriuso, D. Dalal, R.A. Riemersma, L.J. Appel, and E. Guallar Meta-analysis: high-dosage Vitamin E supplementation may increase all-cause mortality Ann. Intern. Med. 142 2005 37 46
242. R. Masella, R. Di Benedetto, R. Vari, C. Filesi, and C. Giovannini Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes J. Nutr. Biochem. 16 2005 577 586
243. Y.B. Ji, T.P.M. Akerboom, H. Sies, and J.A. Thomas S-nitrosylation and S-glutathiolation of protein sulfhydryls by S-nitroso glutathione Arch. Biochem. Biophys. 362 1999 67 78
244. H. Karoui, N. Hogg, C. Frejaville, P. Tordo, and B. Kalyanaraman Characterization of sulfur-centered radical intermediates formed during the oxidation of thiols and sulfite by peroxynitrite - ESR-SPIN trapping and oxygen uptake studies J. Biol. Chem. 271 1996 6000 6009
245. C. Hwang, A.J. Sinskey, and H.F. Lodish Oxidized redox state of glutathione in the endoplasmic-reticulum Science 57 1992 1496 1502
246. D.P. Jones, J.L. Carlson, V.C. Mody, J.Y. Cai, M.J. Lynn, and P. Sternberg Redox state of glutathione in human plasma Free Rad. Biol. Med. 28 2000 625 635
247. A. Pastore, G. Federici, E. Bertini, and F. Piemonte Analysis of glutathione: implication in redox and detoxification Clin. Chim. Acta 333 2003 19 39
248. H. Nakamura, K. Nakamura, and J. Yodoi Redox regulation of cellular activation Ann. Rev. Immunol. 15 1997 351 369
249. K. Hirota, M. Murata, Y. Sachi, H. Nakamura, J. Takeuchi, K. Mori, and J. Yodoi Distinct roles of thioredoxin in the cytoplasm and in the nucleus - a two-step mechanism of redox regulation of transcription factor NF-kappa B J. Biol. Chem. 274 1999 27891 27897
250. A.R. Smith, S.V. Shenvi, M. Widlansky, J.H. Suh, and T.M. Hagen Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress Curr. Med. Chem. 11 2004 1135 1146
251. L. Packer, and Y.J. Suzuki Vitamin-E and alpha-lipoate - role in antioxidant recycling and activation of the NF-kappa-b transcription factor Mol. Aspects Med. 14 1993 229 239
252. N. Ramakrishnan, W.W. Wolfe, and G.N. Catravas Radioprotection of hematopoietic tissues in mice by lipoic acid Rad. Res. 130 1992 360 365
253. J. Bustamante, J.K. Lodge, L. Marcocci, H.J. Tritschler, L. Packer, and B.H. Rihn Alpha-lipoic acid in liver metabolism and disease Free Rad. Biol. Med. 24 1998 1023 1039
254. A. Mortensen, L.H. Skibsted, and T.G. Truscott The interaction of dietary carotenoids with radical species Arch. Biochem. Biophys. 385 2001 13 19
255. A. El-Agamey, G.M. Lowe, D.J. McGarvey, A. Mortensen, D.M. Phillip, and T.G. Truscott Carotenoid radical chemistry and antioxidant/pro-oxidant properties Arch. Biochem. Biophys. 430 2004 37 48
256. G.W. Burton, and K.U. Ingold Beta-carotene - an unusual type of lipid antioxidant Science 224 1984 569 573
257. ATBC trial. Cigarette Smoke or Alcohol Consumption May Enhance adverse Effects of Beta Carotene in Vitamin Prevention Trials 1996 National Institute of Health, National Cancer Institute
258. C.A. Rice-Evans, J. Sampson, P.M. Bramley, and D.E. Holloway Why do we expect carotenoids to be antioxidants in vivo? Free Rad. Res. 26 1997 381 398
259. T.A. Kennedy, and D.E. Liebler Peroxyl radical scavenging by beta-carotene in lipid bilayers - effect of oxygen partial-pressure J. Biol. Chem. 267 1992 4658 4663
260. R.M. Niles Signaling pathways in retinoid chemoprevention and treatment of cancer Mut. Res. Fund.-Mol. Mech. Mutagen. 555 2004 81 96
261. Y. Sharoni, M. Danilenko, N. Dubi, A. Ben-Dor, and J. Levy Carotenoids and transcription Arch. Biochem. Biophys. 430 2004 89 96
262. M. Karas, H. Amir, D. Fishman, M. Danilenko, S. Segal, A. Nahum, A. Koifmann, Y. Giat, J. Levy, and Y. Sharoni Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells Nutr. Cancer Int. J. 36 2000 101 111
263. C.A. RiceEvans, N.J. Miller, and G. Paganga Structure-antioxidant activity relationships of flavonoids and phenolic acids Free Rad. Biol. Med. 20 1996 933 956
264. C. Rice-Evans Flavonoid antioxidants Curr. Med. Chem. 8 2001 797 807
265. H. Schroeter, C. Boyd, J.P.E. Spencer, R.J. Williams, E. Cadenas, and C. Rice-Evans MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide Neurobiol. Aging 23 2002 861 880
266. M. Polovka, V. Brezova, and A. Stasko Antioxidant properties of tea investigated by EPR spectroscopy Biophys. Chem. 106 2003 39 56
267. A. Damianaki, E. Bakogeorgou, M. Kampa, G. Notas, A. Hatzoglou, S. Panagiotou, C. Gemetzi, E. Kouroumalis, P.M. Martin, and E. Castanas Potent inhibitory action of red wine polyphenols on human breast cancer cells J. Cell. Biochem. 78 2000 429 441
268. G. Galati, and P.J. O'Brien Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties Free Rad. Biol. Med. 37 2004 287 303
269. G.N. Schrauzer Anticarcinogenic effects of selenium Cell. Mol. Life Sci. 57 2000 1864 1873
270. L.C. Clark, G.F. Combs, B.W. Turnbull, E.H. Slate, D.K. Chalker, J. Chow, L.S. Davis, R.A. Glover, G.F. Graham, E.G. Gross, A. Krongrad, J.L. Lesher, H.K. Park, B.B. Sanders, C.L. Smith, and J.R. Taylor Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin a randomized controlled trial - a randomized controlled trial JAMA-J. Am. Med. Assoc. 276 1996 1957 1963
271. W.J. Blot, J.Y. Li, P.R. Taylor, W.D. Guo, S. Dawsey, G.Q. Wang, C.S. Yang, S.F. Zheng, M. Gail, G.Y. Li, Y. Yu, B.Q. Liu, J. Tangrea, Y.H. Sun, F.S. Liu, J.F. Fraumeni, Y.H. Zhang, and B. Li Nutrition intervention trials in linxian, China - supplementation with specific vitamin mineral combinations, cancer incidence, and disease-specific mortality in the general-population J. Natl. Cancer Inst. 85 1993 1483 1492
272. R. Sinha, T.K. Said, and D. Medina Organic and inorganic selenium compounds inhibit mouse mammary cell growth in vitro by different cellular pathways Cancer Lett. 107 1996 277 284
273. V. Makropoulos, T. Bruning, and K. SchulzeOsthoff Selenium-mediated inhibition of transcription factor NF-kappa B and HIV-1 LTR promoter activity Arch. Toxicol. 70 1996 277 283
274. J.D. Hayes, and D.J. Pulford The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance Crit. Rev. Biochem. Mol. Biol. 30 1995 445 600
275. J. Butler Thermodynamic considerations of free radical reactions C.J. Rhodes Toxicology of the Human Environment 2000 Taylor & Francis London 437 453
276. F.Q. Schafer, and G.R. Buettner Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple Free Rad. Biol. Med. 30 2001 1191 1212
277. G. Filomeni, G. Rotilio, and M.R. Ciriolo Cell signalling and the glutathione redox system Biochem. Pharmacol. 64 2002 1057 1064
278. A.P. Arrigo Gene expression and the thiol redox state Free Rad. Biol. Med. 27 1999 936 944
279. L.K. Moran, J.M.C. Guteridge, and G.J. Quinlan Thiols in cellular redox signalling and control Curr. Med. Chem. 8 2001 763 772
280. D.W. Voehringer BCL-2 and glutathione: alterations in cellular redox state that regulate apoptosis sensitivity Free Rad. Biol. Med. 27 1999 945 950
281. A.J. McEligot, S. Yang, and F.L. Meyskens Redox regulation by intrinsic species and extrinsic nutrients in normal and cancer cells Ann. Rev. Nutr. 25 2005 261 295
282. J.C. Kern, and J.P. Kehrer Free radicals and apoptosis: relationships with glutathione, thioredoxin and the Bcl family of proteins Front. Biosci. 10 2005 1727 1738
283. A. Patenaude, M.R.V. Murthy, and M.E. Mirault Emerging roles of thioredoxin cycle enzymes in the central nervous system Cell. Mol. Life Sci. 62 2005 1063 1080
284. S. Seemann, and P. Hainaut Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activity Oncogene 24 2005 3853 3863
285. J.Y. Cai, and D.P. Jones Communication - superoxide in apoptosis - mitochondrial generation triggered by Cytochrome c loss J. Biol. Chem. 273 1998 11401 11404
286. A.M. Evens Motexafin gadolinium: a redox-active tumor selective agent for the treatment of cancer Curr. Opin. Oncol. 16 2004 576 580